BMES 2024

Tomei’s Lab at the Annual meeting of the Biomedical Engineering Society (BMES), Baltimore, MD, October 23-26, 2024

Lab presentations:

  1. Wilkes ZM (Presenter), Beatty L, Creusot RJ, Tomei AA, Modulation of Fibroblastic Reticular Cell Immunomodulatory Phenotype via CRISPR Activation and Interference Platform for Applications in Type 1 Diabetes, Annual meeting of the Biomedical Engineering Society (BMES), Baltimore, MD (October 23-26, 2024); oral presentation, October 25, 2024.

zach-bmes-2024

Top